Showing 581-590 of 2840 results for "".
How Effective Is Your Cosmetic Surgery Practice Content Marketing Strategy?
https://modernaesthetics.com/ma-issues-index/2014-july-aug/how-effective-is-your-cosmetic-surgery-practice-content-marketing-strategy/34618/Focusing on the Body: New Topical Products for Non-Facial Concerns
https://modernaesthetics.com/ma-issues-index/2014-july-aug/focusing-on-the-body-new-topical-products-for-non-facial-concerns/34610/Technology in Business: The Changing Face of Online Marketing
https://modernaesthetics.com/ma-issues-index/2014-may-june/technology-in-business-the-changing-face-of-online-marketing/34638/Top 10 Takeaways Every IV Vitamin Therapy Practice Should Know About the Recent Revisions in USP 797
https://modernaesthetics.com/topics/practice-development/top-10-takeaways-every-iv-vitamin-therapy-practice-should-know-about-the-recent-revisions-in-usp-797/35262/Review the steps necessary to remain USP 797 compliant.Three Ways: Summer Slumps: How Can You Sail Through?
https://modernaesthetics.com/topics/practice-development/summer-slumps-how-can-you-sail-through/34028/If business is lagging during the dog days, here's advice on making the most of the open time.The CO2RE®: The Right Choice for Full-Face Resurfacing
https://modernaesthetics.com/ma-supplements/2018-may-june-supplement2/the-co2re-the-right-choice-for-full-face-resurfacing/34141/Mass Appeal: Vanquish ME Taps Demand for Circumferential Reduction
https://modernaesthetics.com/ma-supplements/2018-may-june-supplement/mass-appeal-vanquish-me-taps-demand-for-circumferential-reduction/34129/Cosmetic Injectables Update: More Developments in Neurotoxins
https://modernaesthetics.com/ma-issues-index/2019-jan-feb/cosmetic-injectables-update-more-developments-in-neurotoxins/34001/A look at the evolving neurotoxins field and the latest data for toxins under investigation.Contour Culture
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/contour-culture/34355/The New Thinking on Minimally Invasive Midface RejuvenationOctane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-combination-treatment-strategies-may-evolve-for-patients-using-glp-1-ras/54706/Arash Moradzadeh, MD, founder of AM Facial Plastics, shares his perspective on aesthetic treatments and trends poised to disrupt the market in 2026. He discusses the expanding role of GLP-1 RA medications in aesthetics, including what’s on the horizon for these therapies.